• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO KG PROGAV VALVE; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO KG PROGAV VALVE; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FV410T
Device Problem Mechanical Problem (1384)
Patient Problem Hydrocephalus (3272)
Event Date 11/06/2023
Event Type  Injury  
Manufacturer Narrative
Investigation: visual inspection: during the investigation, visible deposits in the inlet spout was determined.With the measurement of the plane parallelism could be determined with a value of -0.044 mm [outside the tolerance of 0 ± 0.02 mm] a deformation.Permeability test: a permeability test has shown that the valve is permeable.Computer control test: to investigate the flow in valve the opening pressure is measured using a miethke computer control test bench which simulates a cerebrospinal fluid flow.The valve is tested in the horizontal position.The results show that the valve is not operating within the acceptable tolerance in the horizontal position.A reduced outflow could be determined.Adjustment test: the progav was tested and is not adjustable.Braking force and brake function test: the brake functionality test has shown that the brake function is operational.However, the braking force cannot be measured due to the non-adjustability of the valve.Internal inspection: after dismantling of the valve, deposits were found in progav.Result : based on our investigation results, we can determine a reduction of outflow and adjustment difficulties.The determined deposits can be named as the cause for the functional deviations.Organic deposits in the cerebrospinal fluid can influence the function temporarily and are known side effects in hydrocephalus therapy.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when released from christoph miethke gmbh & co.Kg.No further regulatory actions are required from our point of view.
 
Event Description
It was reported that a progav (#fv410t) was implanted during a procedure performed on (b)(6) 2022.According to the complainant, the valve was believed to be not adjustable.The patient underwent a revision procedure.The complainant device was returned to the manufacturer for evaluation.No patient complications were reported as a result of the revision procedure.Age: 15 months.Height: 64 cm.Weight: 7.58 kg.Gender: male.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROGAV VALVE
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM  14469
Manufacturer (Section G)
CHRISTOPH MIETHKE GMBH & CO KG
ulanenweg 2
potsdam, 14469
GM   14469
Manufacturer Contact
joerg knebel
ulanenweg 2
potsdam, 14469
GM   14469
MDR Report Key18251071
MDR Text Key329553658
Report Number3004721439-2023-00361
Device Sequence Number1
Product Code JXG
UDI-Device Identifier04041906132071
UDI-Public4041906132071
Combination Product (y/n)N
Reporter Country CodeSN
PMA/PMN Number
K103003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,User Facility,Company Representative
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 12/01/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberFV410T
Device Catalogue NumberFV410T
Device Lot Number20060189
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/21/2023
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/09/2023
Initial Date FDA Received12/01/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/06/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age15 MO
Patient SexMale
Patient Weight8 KG
-
-